Cargando…
Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
Gene therapy techniques and genetic knowledge may sufficiently advance, within the next few decades, to support prophylactic gene therapy for the prevention of polygenic late-onset diseases. The risk of these diseases may, hypothetically, be lowered by correcting the effects of a subset of common lo...
Autor principal: | Oliynyk, Roman Teo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651814/ https://www.ncbi.nlm.nih.gov/pubmed/31288412 http://dx.doi.org/10.3390/ijms20133352 |
Ejemplares similares
-
Future Preventive Gene Therapy of Polygenic Diseases from a Population Genetics Perspective
por: Oliynyk, Roman Teo
Publicado: (2019) -
Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
por: Oliynyk, Roman Teo
Publicado: (2019) -
Age-related late-onset disease heritability patterns and implications for genome-wide association studies
por: Oliynyk, Roman Teo
Publicado: (2019) -
Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023) -
Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)